{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:23:14Z","timestamp":1760908994292},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.intimp.2016.07.006","type":"journal-article","created":{"date-parts":[[2016,7,10]],"date-time":"2016-07-10T11:00:40Z","timestamp":1468148440000},"page":"41-47","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["MicroRNA expression profiling of Chinese follicular lymphoma by microarray: A preliminary study"],"prefix":"10.1016","volume":"39","author":[{"given":"Yi","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2016.07.006_bb0005","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PDM.0b013e3182585c3c","article-title":"Frequencies of BCL2 and BCL6 translocations in representative Chinese follicular lymphoma patients: morphologic, immunohistochemical, and FISH analyses","volume":"21","author":"Pan","year":"2012","journal-title":"Diagn. Mol. Pathol."},{"key":"10.1016\/j.intimp.2016.07.006_bb0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.beha.2011.02.003","article-title":"Pathology, pathogenesis and molecular genetics of follicular NHL","volume":"24","author":"Leich","year":"2011","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.intimp.2016.07.006_bb0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1158\/2159-8290.CD-11-0209","article-title":"The emergence of lncRNAs in cancer biology","volume":"1","author":"Prensner","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2016.07.006_bb0020","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/482310a","article-title":"Molecular biology: RNA discrimination","volume":"482","author":"Kowalczyk","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2016.07.006_bb0025","doi-asserted-by":"crossref","first-page":"11813","DOI":"10.18632\/oncotarget.2952","article-title":"A microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderly","volume":"5","author":"Andrade","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2016.07.006_bb0030","first-page":"192","article-title":"Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks","volume":"10","author":"Gomez","year":"2013","journal-title":"Cancer Biol Med."},{"key":"10.1016\/j.intimp.2016.07.006_bb0035","doi-asserted-by":"crossref","first-page":"959461","DOI":"10.1155\/2014\/959461","article-title":"MicroRNAs: novel players in cancer diagnosis and therapies","volume":"2014","author":"Oom","year":"2014","journal-title":"Biomed Res Int."},{"key":"10.1016\/j.intimp.2016.07.006_bb0040","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/1471-2407-13-280","article-title":"Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer","volume":"13","author":"Yong","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.intimp.2016.07.006_bb0045","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.18632\/oncotarget.1682","article-title":"microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers","volume":"5","author":"Gasparini","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2016.07.006_bb0050","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bone.2013.05.020","article-title":"MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1","volume":"56","author":"Ji","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.intimp.2016.07.006_bb0055","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.18632\/oncotarget.1747","article-title":"Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity","volume":"5","author":"Raimondi","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2016.07.006_bb0060","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/carcin\/bgs179","article-title":"miR-181a\/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes","volume":"33","author":"Zhu","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.intimp.2016.07.006_bb0065","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1158\/0008-5472.CAN-13-2038","article-title":"miR-155 drives telomere fragility in human breast cancer by targeting TRF1","volume":"74","author":"Dinami","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2016.07.006_bb0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11010-013-1872-7","article-title":"MicroRNA-205suppresses the oral carcinoma oncogenic activity via down-regulation of Axin-2 in KB human oral cancer cell","volume":"387","author":"Kim","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.intimp.2016.07.006_bb0075","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/bjc.2014.51","article-title":"MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients","volume":"110","author":"Pichler","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2016.07.006_bb0080","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/ijc.24880","article-title":"Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer","volume":"126","author":"Shi","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2016.07.006_bb0085","doi-asserted-by":"crossref","first-page":"25556","DOI":"10.1074\/jbc.M111.221564","article-title":"MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis","volume":"286","author":"Tian","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2016.07.006_bb0090","first-page":"465","article-title":"Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27kip1, p57kip2, and PUMA","volume":"3","author":"Sarkar","year":"2013","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.intimp.2016.07.006_bb0095","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajpath.2012.03.013","article-title":"Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma","volume":"181","author":"Huang","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2016.07.006_bb0100","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1038\/onc.2011.470","article-title":"Myc represses miR-15a\/miR-16\u20131 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas","volume":"31","author":"Zhang","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2016.07.006_bb0105","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.molonc.2012.09.006","article-title":"MicroRNA and cancer","volume":"6","author":"Jansson","year":"2012","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.intimp.2016.07.006_bb0110","doi-asserted-by":"crossref","first-page":"E1695","DOI":"10.1073\/pnas.1201516109","article-title":"Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma","volume":"109","author":"Babar","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2016.07.006_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013735","article-title":"A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer","volume":"5","author":"Zhao","year":"2010","journal-title":"PLoS One"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916302752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916302752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T05:11:41Z","timestamp":1718687501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576916302752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":23,"alternative-id":["S1567576916302752"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2016.07.006","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA expression profiling of Chinese follicular lymphoma by microarray: A preliminary study","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2016.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}